CAS No. |
1370264-16-6 |
|---|---|
中文名称 |
(2R,3R,4S,5S,6R)-2-(((3R,8R,10R,12S,13S,14S,17S)-12-羟基-17-((E)-6-羟基-6-甲基庚-2-烯-2-基)-4,4,8,10,14-五甲基十六氢-1H-环戊并[a]菲-3-基)氧基)-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇 |
英文名称 |
(2R,3R,4S,5S,6R)-2-(((3R,8R,10R,12S,13S,14S,17S)-12-Hydroxy-17-((E)-6-hydroxy-6-methylhept-2-en-2-yl)-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
别名 |
23-O-β-D-glucopyranosyl-3β,12β,25-trihydroxyl daMMar-(E)-20(22)-ene;Pseudoginsenoside Rh;Pseudoginsenoside Rh2;(3beta,12beta,20E)-12,25-Dihydroxydammar-20(22)-en-3-yl beta-D-glucopyranoside;Ginsenoside Rh10;β-D-Glucopyranoside, (3β,12β,20E)-12,25-dihydroxydammar-20(22)-en-3-yl;23-O-β-D-glucopyranosyl-3β,12β,25-trihydroxyl daMMar-(E)-20(22)-ene USP/EP/BP;3-O-β-D-glucopyranosyl-3β,12β,25-trihydroxyldammar-(E)-20(22)-ene |
标准英文名 |
(2R,3R,4S,5S,6R)-2-(((3R,8R,10R,12S,13S,14S,17S)-12-hydroxy-17-((E)-6-hydroxy-6-methylhept-2-en-2-yl)-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
MDL No. |
MFCD29917908 |
分子式 |
C36H62O8 |
分子量 |
622.88 |
精确分子量 |
622.44 |
SMILES |
C/C(=C\CCC(C)(C)O)[C@H]1CC[C@@]2(C)[C@H]1[C@@H](O)CC1[C@@]3(C)CC[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)C3CC[C@]12C |
标准SMILES |
CC(C)(O)CC/C=C(\C)/[C@H]1CC[C@@]2(C)[C@H]1[C@@H](O)CC1[C@@]2(C)CCC2[C@]1(C)CC[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C2(C)C |
性状 |
No data available |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Danger |
InChIKey |
YCDZBVXSGVWFFX-XSBYJJAFSA-N |
危险类别(旧) |
H301 |
存储要求 |
No data available,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral , acute toxicity, dermal and acute toxicity, inhalation(Category 3) |
|---|---|
UN No. |
2811,2811,2811 |
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|